At VivaTech in Paris, research center coordinators showcase the advances made at the University of São Paulo in agriculture, climate, energy, computing, artificial intelligence, and health.
Scientists from the Curie Institute and the University of São Paulo are about to conduct a clinical study to evaluate the safety and efficacy of a new CAR-T cell-based immunotherapy for patients with oculocerebral lymphoma; the project was presented at FAPESP Week in Toulouse.
Researchers from the University of São Paulo have identified a molecule in arachnid venom that acts similarly to a commonly used chemotherapy drug for treating the disease; preliminary results of the study were presented at FAPESP Week France.
